Henry Tam

Papers

Total Citations

H-Index

About

Henry Tam is a leading urologic researcher whose work centers on advancing prostate cancer diagnostics through robotic-assisted biopsy technologies. His most influential contribution is the prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach, a landmark study with 38 citations that established the clinical viability of transperineal prostate biopsy with pre-programmed standardized schemes. This work demonstrated how robotic systems could enhance precision and reproducibility in prostate tissue sampling, directly addressing limitations of traditional manual biopsy methods. Tam's research has been instrumental in validating the transition from cognitive fusion to automated, robotically guided biopsy platforms, improving cancer detection rates while reducing patient morbidity. His prospective data collection across 86 consecutive men provided critical evidence for the safety and efficacy of this emerging technology. Beyond this seminal paper, Tam continues to investigate the integration of artificial intelligence and robotics in urologic oncology, positioning him as a key figure in the evolution of minimally invasive prostate cancer diagnosis. His work bridges engineering innovation with clinical application, offering tangible improvements in diagnostic accuracy for patients worldwide.